Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Alyssa Sharon Baker, M.D.
Family Practice · ALLISON PARK, PA · NPI 1962994475
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 602 | 157 |
| Levothyroxine Sodium | Levothyroxine Sodium | 524 | 124 |
| Amlodipine Besylate | Amlodipine Besylate | 360 | 108 |
| Lisinopril | Lisinopril | 301 | 85 |
| Sertraline Hcl | Sertraline Hcl | 290 | 67 |
| Eliquis | Apixaban | 275 | 56 |
| Pantoprazole Sodium | Pantoprazole Sodium | 227 | 69 |
| Omeprazole | Omeprazole | 213 | 69 |
| Metformin Hcl | Metformin Hcl | 186 | 59 |
| Gabapentin | Gabapentin | 183 | 56 |
| Losartan Potassium | Losartan Potassium | 178 | 53 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 176 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 167 | 50 |
| Furosemide | Furosemide | 163 | 53 |
| Metoprolol Succinate | Metoprolol Succinate | 153 | 43 |
| Trazodone Hcl | Trazodone Hcl | 150 | 46 |
| Potassium Chloride | Potassium Chloride | 144 | 40 |
| Irbesartan | Irbesartan | 133 | 33 |
| Simvastatin | Simvastatin | 126 | 29 |
| Citalopram Hbr | Citalopram Hydrobromide | 124 | 32 |
| Quetiapine Fumarate | Quetiapine Fumarate | 117 | 28 |
| Escitalopram Oxalate | Escitalopram Oxalate | 116 | 31 |
| Famotidine | Famotidine | 115 | 37 |
| Tamsulosin Hcl | Tamsulosin Hcl | 113 | 30 |
| Carvedilol | Carvedilol | 112 | 31 |
| Donepezil Hcl | Donepezil Hcl | 112 | 25 |
| Duloxetine Hcl | Duloxetine Hcl | 108 | 34 |
| Hydrochlorothiazide | Hydrochlorothiazide | 106 | 34 |
| Jardiance | Empagliflozin | 99 | 26 |
| Mirtazapine | Mirtazapine | 95 | 26 |
| Tramadol Hcl | Tramadol Hcl | 91 | 30 |
| Alendronate Sodium | Alendronate Sodium | 89 | 29 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 81 | 30 |
| Allopurinol | Allopurinol | 80 | 22 |
| Fluticasone Propionate | Fluticasone Propionate | 80 | 28 |
| Finasteride | Finasteride | 73 | 14 |
| Metformin Hcl Er | Metformin Hcl | 72 | 22 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 69 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 69 | 15 |
| Ozempic | Semaglutide | 66 | 15 |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 15 |
| Meloxicam | Meloxicam | 65 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 62 | 22 |
| Lorazepam | Lorazepam | 61 | 32 |
| Valsartan | Valsartan | 61 | 21 |
| Montelukast Sodium | Montelukast Sodium | 60 | 17 |
| Oxycodone Hcl | Oxycodone Hcl | 57 | 19 |
| Prednisone | Prednisone | 56 | 38 |
| Atenolol | Atenolol | 54 | 19 |
| Celecoxib | Celecoxib | 54 | 20 |
| Olanzapine | Olanzapine | 54 | 12 |
| Xarelto | Rivaroxaban | 54 | 13 |
| Alprazolam | Alprazolam | 51 | 18 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 50 | 13 |
| Nystatin | Nystatin | 45 | 29 |
| Memantine Hcl | Memantine Hcl | 44 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 43 | 15 |
| Clonazepam | Clonazepam | 43 | 14 |
| Mounjaro | Tirzepatide | 43 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 41 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 41 | 14 |
| Warfarin Sodium | Warfarin Sodium | 40 | 12 |
| Indapamide | Indapamide | 39 | 12 |
| Pregabalin | Pregabalin | 39 | 11 |
| Bupropion Xl | Bupropion Hcl | 37 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 37 | 26 |
| Methylprednisolone | Methylprednisolone | 35 | 33 |
| Pravastatin Sodium | Pravastatin Sodium | 35 | 12 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | suppressed |
| Risperidone | Risperidone | 34 | suppressed |
| Glimepiride | Glimepiride | 33 | 14 |
| Azithromycin | Azithromycin | 31 | 30 |
| Bumetanide | Bumetanide | 31 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 29 | 27 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 29 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 28 | suppressed |
| Levetiracetam | Levetiracetam | 28 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 28 | suppressed |
| Ezetimibe | Ezetimibe | 27 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 27 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 27 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 11 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 25 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 25 | 21 |
| Paxlovid | Nirmatrelvir/Ritonavir | 24 | 24 |
| Topiramate | Topiramate | 24 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 23 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 23 | suppressed |
| Spironolactone | Spironolactone | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | 13 |
| Benazepril Hcl | Benazepril Hcl | 22 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 22 | suppressed |
| Latanoprost | Latanoprost | 22 | suppressed |
| Lamotrigine | Lamotrigine | 21 | suppressed |
| Myrbetriq | Mirabegron | 21 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 20 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | 11 |
| Ondansetron Odt | Ondansetron | 20 | 11 |
| Paroxetine Hcl | Paroxetine Hcl | 20 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 19 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 19 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 19 | 18 |
| Cephalexin | Cephalexin | 18 | 16 |
| Loperamide | Loperamide Hcl | 18 | 18 |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 17 | 13 |
| Glipizide Er | Glipizide | 17 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 17 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 16 | 11 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 16 | 16 |
| Jantoven | Warfarin Sodium | 16 | suppressed |
| Synthroid | Levothyroxine Sodium | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Baclofen | Baclofen | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 13 |
| Folic Acid | Folic Acid | 15 | suppressed |
| Naltrexone Hcl | Naltrexone Hcl | 15 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 14 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | suppressed |
| Fetzima | Levomilnacipran Hcl | 14 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 14 | suppressed |
| Carbamazepine | Carbamazepine | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 12 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 12 | 12 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 12 | 12 |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 11 | suppressed |
| Glipizide | Glipizide | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Rizatriptan | Rizatriptan Benzoate | 11 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 11 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Trulicity | Dulaglutide | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error